BIOMAT Database Logo BIOMAT Database Logo

Single-dose and steady-state pharmacokinetics of doxazosin given in combination with chlorothiazide to hypertensive subjects. 1989

E L Conway, and J J McNeil, and L Meng, and O H Drummer, and L G Howes, and K Raymond, and W J Louis
University of Melbourne, Clinical Pharmacology and Therapeutics Units, Austin Hospital, Heidelberg, Victoria, Australia.

The pharmacokinetics of doxazosin were determined in hypertensive subjects after a single dose of 1 mg, and at steady-state while receiving doses of 1, 2, 4 and 8 mg of the drug daily. Chlorothiazide 500 mg once daily was administered as additional therapy throughout the study. After a single dose doxazosin was rapidly absorbed, with peak plasma drug concentrations (Cmax) occurring after 2.1 +/- 0.4 hours. The elimination half-life in plasma was 10.7 +/- 1.2 hours. These parameters remained essentially unchanged during maintenance administration of doxazosin at each of the dose levels. Calculations of Cmax and area under the concentration-time curve (AUC0----infinity) indicated that the pharmacokinetic disposition of the drug remained linear over the dose range 1 to 8 mg.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002740 Chlorothiazide A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p812)
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E L Conway, and J J McNeil, and L Meng, and O H Drummer, and L G Howes, and K Raymond, and W J Louis
The pharmacokinetics of ketanserin after a single dose and at steady-state in hypertensive subjects.
January 1987, European journal of clinical pharmacology,
E L Conway, and J J McNeil, and L Meng, and O H Drummer, and L G Howes, and K Raymond, and W J Louis
Single-dose and steady-state pharmacokinetics of tomoxetine in normal subjects.
January 1985, Journal of clinical pharmacology,
E L Conway, and J J McNeil, and L Meng, and O H Drummer, and L G Howes, and K Raymond, and W J Louis
Single intravenous dose and steady-state oral dose pharmacokinetics of nicardipine in healthy subjects.
January 1987, Biopharmaceutics & drug disposition,
E L Conway, and J J McNeil, and L Meng, and O H Drummer, and L G Howes, and K Raymond, and W J Louis
Comparative single dose and steady-state pharmacokinetics of bevantolol in young and elderly subjects.
January 1986, European journal of clinical pharmacology,
E L Conway, and J J McNeil, and L Meng, and O H Drummer, and L G Howes, and K Raymond, and W J Louis
Single-dose and steady-state pharmacokinetics of aminoglutethimide.
January 1985, Clinical pharmacokinetics,
E L Conway, and J J McNeil, and L Meng, and O H Drummer, and L G Howes, and K Raymond, and W J Louis
Single dose and steady state pharmacokinetics of temocapril and temocaprilat in young and elderly hypertensive patients.
October 1998, British journal of clinical pharmacology,
E L Conway, and J J McNeil, and L Meng, and O H Drummer, and L G Howes, and K Raymond, and W J Louis
Single dose and steady state pharmacokinetics and pharmacodynamics of the ACE-inhibitor imidapril in hypertensive patients.
April 1998, British journal of clinical pharmacology,
E L Conway, and J J McNeil, and L Meng, and O H Drummer, and L G Howes, and K Raymond, and W J Louis
Steady state pharmacokinetics and dose-proportionality of phenylpropanolamine in healthy subjects.
April 1990, Journal of clinical pharmacology,
E L Conway, and J J McNeil, and L Meng, and O H Drummer, and L G Howes, and K Raymond, and W J Louis
Single-dose and steady-state pharmacokinetics of celecoxib in children.
November 2002, Clinical pharmacology and therapeutics,
E L Conway, and J J McNeil, and L Meng, and O H Drummer, and L G Howes, and K Raymond, and W J Louis
Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin.
September 1996, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!